NDC 58118-1189 – Buprenorphine hydrochloride and naloxone hydrochloride dihydrate

Buprenorphine Hydrochloride 8 mg/1; Naloxone Hydrochloride Dihydrate 2 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC58118-1189

Product details

Brand name
Buprenorphine hydrochloride and naloxone hydrochloride dihydrate
Generic name
Buprenorphine hydrochloride and naloxone hydrochloride dihydrate
Labeler
Clinical Solutions Wholesale, LLC
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA203326
Marketed since
June 27, 2014
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE →

Package NDC codes (1)

Package NDCDescriptionSince
58118-1189-830 TABLET in 1 BLISTER PACK (58118-1189-8)Mar 4, 2026

Other BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE products